MEP47408A - Formulacije hfa-suspenzija koje sadrže antiholinergik - Google Patents

Formulacije hfa-suspenzija koje sadrže antiholinergik

Info

Publication number
MEP47408A
MEP47408A MEP-474/08A MEP47408A MEP47408A ME P47408 A MEP47408 A ME P47408A ME P47408 A MEP47408 A ME P47408A ME P47408 A MEP47408 A ME P47408A
Authority
ME
Montenegro
Prior art keywords
hfa
anticholinergic
formulations containing
suspension formulations
suspension
Prior art date
Application number
MEP-474/08A
Other languages
English (en)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP47408(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MEP47408A publication Critical patent/MEP47408A/hr
Publication of ME00247B publication Critical patent/ME00247B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Pronalazak se odnosi na formulaciju, sa potisnim gasom, suspenzije, kristalnog monohidrata (1α, 2β, 4β, 5α, 7β)-7-[(hidfroksidi-2-tienilacetil)oksi]-9,9-dimetil-3-oksa-9-azoniatriciklo[3.3.1.02,4]nonan-bromida.
MEP-2008-474A 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže antiholinergik ME00247B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214263A DE10214263A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
PCT/EP2003/002898 WO2003082252A1 (de) 2002-03-28 2003-03-20 Hfa-suspensionsformulierungen enthaltend ein anticholinergikum

Publications (2)

Publication Number Publication Date
MEP47408A true MEP47408A (hr) 2011-02-10
ME00247B ME00247B (me) 2011-05-10

Family

ID=28050989

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-474A ME00247B (me) 2002-03-28 2003-03-20 Formulacije hfa-suspenzija koje sadrže antiholinergik

Country Status (27)

Country Link
EP (2) EP1492513B1 (hr)
JP (1) JP4480401B2 (hr)
KR (1) KR101066801B1 (hr)
CN (1) CN1329023C (hr)
AT (1) ATE339953T1 (hr)
AU (1) AU2003209743B2 (hr)
BR (1) BR0308764A (hr)
CA (1) CA2479640C (hr)
CY (1) CY1105543T1 (hr)
DE (2) DE10214263A1 (hr)
DK (1) DK1492513T3 (hr)
EA (1) EA007239B1 (hr)
EC (1) ECSP045321A (hr)
ES (1) ES2273020T3 (hr)
HK (1) HK1079091A1 (hr)
HR (1) HRP20040889B1 (hr)
IL (2) IL163697A0 (hr)
ME (1) ME00247B (hr)
MX (1) MXPA04009337A (hr)
NO (1) NO20044005L (hr)
NZ (1) NZ536043A (hr)
PL (1) PL371296A1 (hr)
PT (1) PT1492513E (hr)
RS (1) RS52178B (hr)
UA (1) UA78557C2 (hr)
WO (1) WO2003082252A1 (hr)
ZA (1) ZA200405638B (hr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005259523B2 (en) † 2004-07-02 2011-06-09 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
GB201200504D0 (en) * 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
EP2705838A1 (en) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium preparations
CN104918604A (zh) * 2012-10-23 2015-09-16 西普拉有限公司 药物组合物
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN107056629B (zh) * 2017-04-27 2019-04-30 河北科技大学 一种无水卤化胆碱及其衍生物单晶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
WO2000007567A1 (de) * 1998-08-04 2000-02-17 Jago Research Ag Medizinische aerosolformulierungen
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
NZ525733A (en) * 2000-10-12 2005-01-28 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
WO2002036106A2 (de) * 2000-10-31 2002-05-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
IL163697A0 (en) 2005-12-18
ECSP045321A (es) 2005-01-28
CA2479640C (en) 2010-09-28
BR0308764A (pt) 2005-01-11
AU2003209743A1 (en) 2003-10-13
YU85904A (sh) 2006-08-17
ZA200405638B (en) 2005-07-27
EP1695701A3 (de) 2010-04-28
ATE339953T1 (de) 2006-10-15
NZ536043A (en) 2005-09-30
EA007239B1 (ru) 2006-08-25
AU2003209743B2 (en) 2008-03-06
PL371296A1 (en) 2005-06-13
WO2003082252A1 (de) 2003-10-09
RS52178B (sr) 2012-10-31
EP1695701B1 (de) 2015-01-07
HK1079091A1 (en) 2006-03-31
JP2005529087A (ja) 2005-09-29
CY1105543T1 (el) 2010-07-28
IL163697A (en) 2011-03-31
KR20040098031A (ko) 2004-11-18
CN1329023C (zh) 2007-08-01
DE50305118D1 (de) 2006-11-02
ME00247B (me) 2011-05-10
HRP20040889B1 (hr) 2012-11-30
CA2479640A1 (en) 2003-10-09
EP1695701A2 (de) 2006-08-30
NO20044005L (no) 2004-10-05
DK1492513T3 (da) 2006-12-18
DE10214263A1 (de) 2003-10-16
HRP20040889A2 (en) 2004-12-31
PT1492513E (pt) 2006-12-29
CN1642534A (zh) 2005-07-20
JP4480401B2 (ja) 2010-06-16
MXPA04009337A (es) 2005-01-25
EA200401190A1 (ru) 2005-04-28
ES2273020T3 (es) 2007-05-01
UA78557C2 (en) 2007-04-10
EP1492513A1 (de) 2005-01-05
EP1492513B1 (de) 2006-09-20
KR101066801B1 (ko) 2011-09-22

Similar Documents

Publication Publication Date Title
MEP40608A (hr) Postupak za pripremanje antiholinergikuma, tiotropijumbromida
EA200401142A1 (ru) Микронизированный кристаллический тиотропийбромид
MEP62008A (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
MEP40008A (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
CY1105543T1 (el) Σκευασματα εναιωρηματων με hfa που περιεχουν αντιχολινεργικο
WO2002072095A3 (de) Tiotropiumsalzen zur behandlung von inflammatorischen erkrankungen
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
MEP47308A (hr) Formulacija hfa-suspenzije koje sadrži anhidrat
MX9301824A (es) Metabolitos hidroxilados y derivados de boxazosin como agentes anti-ateroscleroticos.
ECSP034921A (es) Anticolinérgico cristalino, metodo para su producción, y uso del mismo en la producción de una droga
FI896173A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 1-(5-amino-7-fenyyli/1,2,4/triatsolo/1,5-c/pyrimidin-5-yyli)-1,2-etaanidiolin valmistamiseksi